Table I.
Cytological outcomes in treated and untreated patients.
| Negative cytology, no. (%) | ASCUS, no. (%) | LSIL, no. (%) | HSIL, no. (%) | No Pap test no. (%) | Total no. | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Time | Treated | Control | P-value | Treated | Control | Treated | Control | Treated | Control | Treated | Control | S Stop EA complex, no. | Treated | Control |
| Baseline | 21 (42) | 18 (34) | 8 (16) | 11 (21) | 20 (40) | 24 (46) | 1 (2) | 0 (0) | 0 (0) | 0 (0) | 0 | 50 | 53 | |
| 6 months | 36 (74) | 33 (63) | 0.041a | 2 (4) | 2 (4) | 6 (12) | 15 (28) | 0 (0) | 3 (6) | 5 (10) | 0 (0) | 1 | 49 | 53 |
| 12 months | 40 (82) | 30 (60) | 0.014a | 2 (4) | 3 (6) | 2 (4) | 12 (24) | 3 (6) | 3 (6) | 2 (4) | 2 (4) | 0 | 49 | 50 |
a
P<0.05; ASCUS, atypical cells of undetermined significance; LSIL, low-grade squamous intraepithelial lesions; HSIL, high-grade squamous intraepithelial lesions; EA, ellagic acid.